2021 ISPE Facilities of the Future Conference

The 2021 ISPE Facilities of the Future Conference will explore advancements in pharmaceutical technology and what pharmaceutical manufacturing facilities will look like in the future.   Featuring technical and inspirational presentations from industry leaders already planning and building “facilities of the future” this conference will look at new manufacturing challenges, technologies, and regulatory factors impacting the ability of today’s companies to stay competitive and cost-effective.  Speed to market is often a key requirement in project delivery but even more so with the COVID19 pandemic, and so facility design and project execution approaches that focus on meeting this element will also be covered.

The conference will look at both new and legacy pharmaceutical facilities as both must be efficient and cGMP compliant while adopting emerging technologies to improve drug quality.  We would also like to explore the impact of disruptive technologies and Pharma 4.0, highly automated processes using the Internet of Things (IoT), Artificial Intelligence (AI), robotics, advanced analytics, the use of digital twins, and machine learning. Additionally, facility designs that embrace the attributes of facilities of the future such as adaptability and flexibility will be included, with a particular emphasis on single-use, regenerative medicines and drug product facilities.

This program will bring together diverse experts to share best practices and benchmark solutions for new and existing facilities.


Featured Speakers


Why Attend?

  • Learn how award-winning industry leaders successfully implemented technology innovations in facility design including virtual reality, artificial intelligence and automation 
  • Interact with industry and regulatory thought leaders about addressing key issues in pharmaceutical manufacturing facilities today 
  • Identify current challenges in facility design and define the “procedures” of the future 
  • Learn from industry leaders about their approaches to cybersecurity, lifecycle engineering and plant asset management for the facility of the future 

Conference Topics:

  • Continuous Manufacturing 
  • Design and Operations of Cell & Gene Therapy and other Biotech Facilities  
  • Application of Single Use Technology   
  • Industry 4.0 / Pharma 4.0 
  • Big Data
  • Innovative manufacturing concepts due to new supply chain requirements 
  • Artificial Intelligence (AI) in the design, manufacture or operation of Pharma Facilities 
  • Robotics and Digital Technologies  
  • Combination Product Manufacturing 
  • Emerging Technologies  
  • Industry Trends 

Who Should Attend

This conference provides relevant content of interest to all levels of professionals in the pharmaceutical engineering field, especially those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.

Emerging Leaders Senior Executives Communities of Practice Special Interest Groups Equipment and Services Suppliers Regulatory Professionals


Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Facilities of the Future Conference.
Name
Company Type

Program Committee

Jeffrey A. Biskup, PE
CEO and Chairman of the Board
CRB
Chair
Michael Martin
President
CAI
Co-Chair
Lou W. Kennedy
CEO and Owner
Nephron Pharmaceuticals
Board Liaison
James A. Breen, Jr., PE
Vice President, Lead Biologics Expansion
Janssen Pharmaceuticals
Mark A. Butler
President and Managing Director
IPS
Austin G. Lock
Technical Director & Deputy Pharmaceutical Sector Director
PM Group
Brian K. Vaughn
Co-Chair, North America/South America Affiliate Council
CRB
Placeholder Person Graphic
Elizabeth Gosen
SVP, Technical Operations
Legend Biotech
Lindsey E. Daniel, PE
Process Engineering Manager
Takeda Pharmaceuticals - Apotekerstien 9 9500 HOBRO DENMARK
Tara Tibbs
Sr Director Engineering API/DP
Eli Lilly & Co